Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

312
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
312
Antibiotic Selection00:57

Antibiotic Selection

56.6K
Overview
56.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

466
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
466
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.6K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

131
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
131
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026
Same author

Genomic scale analysis of assembly-line polyketide synthase diversity and evolution.

Natural product reports·2026
Same author

A Streptomyces megacluster encodes synergistic biotin-targeting antibiotics.

Nature·2026
Same author

A natural depsipeptide antibiotic binds the E-site of the bacterial ribosome.

Nature·2026
Same author

Activating p53<sup>Y220C</sup> with a mutant-specific small molecule.

Nature communications·2026
Same author

Charged molecular glue discovery enabled by targeted degron display.

Nature chemical biology·2026

関連する実験動画

Updated: Oct 11, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.1K

抗菌薬 の 発見 と 開発 の 見通し

Thomas M Privalsky, Alexander M Soohoo, Jinhua Wang1,2

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.

Journal of the American Chemical Society
|December 3, 2021
PubMed
まとめ
この要約は機械生成です。

抗生物質耐性対策には 新しい投資と多面的なアプローチが必要です 既存の抗菌標的を再評価し,新しい発見方法を探求することは,耐性細菌に対する効果的な治療法の開発に不可欠です.

さらに関連する動画

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

980
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

関連する実験動画

Last Updated: Oct 11, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

11.1K
Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

980
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

科学分野:

  • 微生物 学 と 感染症
  • 薬の発見と開発
  • 抗菌剤に対する耐性

背景:

  • 多剤耐性細菌の蔓延は 世界的に深刻な健康問題となっています
  • 抗生物質の発見と開発のための既存の戦略は,この危機に対処するために大幅に強化する必要があります.

研究 の 目的:

  • 抗生物質の発見と開発への新たな投資を提唱する
  • 検証された抗菌標的と鉛分子の再検討の可能性を強調する.
  • 新しい抗生物質を特定するための革新的なアプローチを探求する.

主な方法:

  • 抗生物質の発見のための既存の戦略と新興戦略の検討
  • ゲノムマイニングの可能性を分析し,未開発の生態学的ニッチを探索する.
  • 多剤療法と抵抗性酵素の阻害剤の適用を検討する.

主要な成果:

  • 多くの抗菌標的と鉛分子が検証されていて,さらなる調査が必要である.
  • ゲノムマイニングや 新しい環境の探索など 新しい発見技術が有望です
  • 薬剤耐性のメカニズムを標的とし ポリファーマコロジーを採用することで 薬の開発の新たな道が開けます

結論:

  • 抗生物質耐性危機と闘うには 多面的な戦略が不可欠です
  • 新しい抗生物質の発見と開発には 新たな投資と創造的なアプローチが不可欠です
  • 抗菌薬の研究開発を支援するために,薬学経済モデルを開発する必要があります.